Virtus LifeSci Biotech Products ETF Rating $63.19 +0.23 (+0.37%) As of 10:17 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.81Holdings in BBP have an aggregate rating of Moderate Buy based on 325 analyst ratings issued in the past year covering 25 companies (50.7% of the portfolio).BBP Aggregate Price Target$63.230.06% UpsideHigh Prediction$63.23Average Prediction$63.23Low Prediction$63.23Holdings in BBP have an aggregate price target of $63.23 and a range of $63.23 to $63.23 covering 25 companies (50.7% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.84%CRSPCRISPR Therapeutics$54.91-1.9%3.6738 of 5 stars2.50$71.60 30.4%16Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.47%RYTMRhythm Pharmaceuticals$92.05-0.5%3.5671 of 5 stars3.07$101.57 10.3%15Earnings ReportAnalyst ForecastAnalyst Revision2.41%IOVAIovance Biotherapeutics$2.13-19.5%4.6967 of 5 stars2.33$11.67 449.0%12Earnings ReportAnalyst Forecast2.13%MRNAModerna$26.44-0.6%4.324 of 5 stars2.04$43.59 64.8%24Earnings ReportAnalyst Revision2.11%ARDXArdelyx$5.22+1.5%4.3377 of 5 stars3.00$11.50 120.5%10Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.09%IONSIonis Pharmaceuticals$41.12+0.2%4.4986 of 5 stars2.86$59.38 44.4%14Insider TradeAnalyst Revision2.06%LEGNLegend Biotech$37.55+0.3%3.8484 of 5 stars3.00$73.33 95.3%11News CoveragePositive NewsUpcoming EarningsAnalyst Revision2.06%LGNDLigand Pharmaceuticals$146.71+0.3%3.5201 of 5 stars3.00$150.00 2.2%6News CoveragePositive News2.05%BBIOBridgeBio Pharma$45.59-0.8%4.7221 of 5 stars3.00$61.35 34.6%17News CoverageEarnings ReportAnalyst ForecastInsider TradeOptions VolumeAnalyst Revision2.04%AGIOAgios Pharmaceuticals$36.76-0.8%4.0503 of 5 stars2.75$56.33 53.3%81.95%HRMYHarmony Biosciences$33.86-1.0%4.7051 of 5 stars3.00$51.00 50.6%10Earnings ReportAnalyst Revision1.92%KRYSKrystal Biotech$134.14-1.4%4.8143 of 5 stars3.00$210.22 56.7%10Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision1.92%AUPHAurinia Pharmaceuticals$11.59+1.4%2.1475 of 5 stars3.00$12.00 3.6%3Insider Trade1.91%DVAXDynavax Technologies$10.93-1.2%4.3083 of 5 stars2.50$24.00 119.7%4News CoveragePositive NewsEarnings Report1.91%REGNRegeneron Pharmaceuticals$561.83+0.4%4.9053 of 5 stars2.75$832.73 48.2%24Positive NewsEarnings ReportDividend AnnouncementAnalyst Revision1.90%ONCBeOne Medicines$285.07-4.4%1.3099 of 5 stars3.00$330.89 16.1%7Earnings ReportAnalyst ForecastInsider TradeGap Up1.90%ALNYAlnylam Pharmaceuticals$428.19-1.6%3.9138 of 5 stars2.85$403.92 -5.7%27Analyst Forecast1.89%EXELExelixis$37.48+0.2%4.946 of 5 stars2.55$44.44 18.6%221.89%INSMInsmed$107.70-1.5%3.645 of 5 stars3.00$109.20 1.4%17Earnings Report1.89%BNTXBioNTech$111.22-0.1%1.9796 of 5 stars2.76$135.91 22.2%17Earnings ReportAnalyst ForecastGap Up1.89%MIRMMirum Pharmaceuticals$59.39-0.7%3.3513 of 5 stars3.14$72.00 21.2%7Trending NewsEarnings ReportAnalyst Forecast1.89%NBIXNeurocrine Biosciences$124.47-0.9%4.9667 of 5 stars2.86$160.90 29.3%221.88%TBPHTheravance Biopharma$11.35+1.2%2.6431 of 5 stars3.33$21.33 88.0%31.87%MDGLMadrigal Pharmaceuticals$341.75-0.2%4.3861 of 5 stars2.88$430.43 25.9%8Positive NewsEarnings ReportAnalyst ForecastAnalyst Revision1.87%HALOHalozyme Therapeutics$62.69+1.0%4.7856 of 5 stars2.18$66.56 6.2%11Positive NewsEarnings ReportAnalyst Forecast This page (NYSEARCA:BBP) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
